New assay promising for confirming anaphylaxis.MIAMI BEACH -- Mast cell carboxypeptidase shows promise as a new clinical marker for anaphylaxis. Dr. Xiaoying Zhou and her associates reported at the annual meeting of the American Academy of Allergy, Asthma, and Immunology.
Assays for tryptase have proved useful in the diagnosis of anaphylaxis, but increased circulating levels of this mast cell product often cannot be detected. Using a pair of specific monoclonal antibodies, CA4 and CA5, British researchers have developed an enzyme-linked immunosorbent assay enzyme-linked immunosorbent assay
Any of various enzymes, including the proteinases and peptidases, that catalyze the hydrolytic breakdown of proteins. that is released with tryptase by activated mast cells and is a mediator of inflammation.
The assay was applied to serum and plasma samples collected within 8 hours of the onset of an allergic reaction in 198 cases of suspected anaphylaxis and in 30 cases of systemic mastocytosis; control groups consisted of 209 healthy blood donors and 15 patients with bronchial asthma.
Carboxypeptidase levels were significantly higher in suspected anaphylaxis than in either control group. In some cases, concentrations were more than 100-fold greater, said Dr. Zhou of the University of Southampton In the most recent RAE assessment (2001)
Levels in the mastocytosis group also were greater than in the control groups in the study, which was funded by the Thrasher Research Fund in Salt Lake City and the London Law Trust.
"Our feeling is that the new assay will be useful in defining cases of anaphylaxis according to a biochemical criteria in addition to clinical assessments," lead author Dr. Andrew Walls commented in an interview. "The test should also be useful as a diagnostic aid in cases of mastocytosis and in other conditions in which mast cell activation is implicated."
In 83% of anaphylaxis cases with an elevated tryptase concentration, carboxypeptidase levels were above the normal range. Out of 110 cases of suspected anaphylaxis that were tryptase negative, 77 (70%) had an elevated concentration of carboxypeptidase, said Dr. Walls of Southampton General Hospital.
Arrangements have not yet been made with a commercial supplier to distribute the assay.
BY PATRICE WENDLING
http://www.thefreelibrary.com/New+assay+promising+for+confirming+anaphylaxis.-a0...